One of our greatest developments to date has taken years off the time it takes for conditional licensing on an animal vaccine. While this process traditionally takes up to five years, RapidxTM offers an innovative development platform that reduces that time to just twelve month.
This platform consists of:
1. Disease Surveillance
This includes the collection of airborne pathogens within a 10 kilometer radius of an agricultural operation. The collection of live viruses alerts the operator to the presence of the virus and provides information for the purpose of product development.
2. In Vitro Screening
Vaccine efficacy screening is conducted in vitro, eliminating the need to infect animals with infectious agents and reducing the time, cost and use of animals in testing vaccinations.
3. Rapid Vaccine Production
Protein-based vaccines versus virus-based vaccines are produced quickly and at a lower cost, allowing for a faster procurement of a conditional license under new USDA-CVB Technology Platform Guidelines.